Interleukin-2-Induced Increases in Climbing Behavior: Inhibition by Dopamine D-1 and D-2 Receptor AntagonistsZalcman, S SAuthor informationBixler Professor of Psychiatry, and Director, Division of Psychopharmacology, Vanderbilt University School of Medicine, Nashville, TennesseeUMD-New Jersey Med School, NewarkYear Book of Psychiatry & Applied Mental Health 2004(1):p 329-330, 2004.Copyright © 2004Elsevier, Inc.